PT86639A - Expressao da proteina da fase de esporozoito de p. falciparum por leveduras - Google Patents

Expressao da proteina da fase de esporozoito de p. falciparum por leveduras

Info

Publication number
PT86639A
PT86639A PT86639A PT8663988A PT86639A PT 86639 A PT86639 A PT 86639A PT 86639 A PT86639 A PT 86639A PT 8663988 A PT8663988 A PT 8663988A PT 86639 A PT86639 A PT 86639A
Authority
PT
Portugal
Prior art keywords
falciparum
yeast
expression
phase protein
sporozoite
Prior art date
Application number
PT86639A
Other languages
English (en)
Inventor
Michel De Wilde
Anne-Marie Gathoye
Original Assignee
Smithkline Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Biolog filed Critical Smithkline Biolog
Publication of PT86639A publication Critical patent/PT86639A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT86639A 1987-01-30 1988-01-27 Expressao da proteina da fase de esporozoito de p. falciparum por leveduras PT86639A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US879187A 1987-01-30 1987-01-30

Publications (1)

Publication Number Publication Date
PT86639A true PT86639A (pt) 1989-01-30

Family

ID=21733689

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86639A PT86639A (pt) 1987-01-30 1988-01-27 Expressao da proteina da fase de esporozoito de p. falciparum por leveduras

Country Status (8)

Country Link
EP (1) EP0278941A1 (pt)
KR (1) KR890700661A (pt)
AU (1) AU1092588A (pt)
DK (1) DK36988A (pt)
FI (1) FI884485A0 (pt)
HU (1) HUT51332A (pt)
PT (1) PT86639A (pt)
WO (1) WO1988005817A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
WO1990007006A1 (en) * 1988-12-21 1990-06-28 Smithkline Biologicals Expression of the plasmodium circumsporozoite protein in insect cells
CA2031468A1 (en) * 1989-12-08 1991-06-09 Mitchell S. Gross Malaria vaccine
CA2037151A1 (en) * 1990-03-23 1991-09-24 F. Hoffmann-La Roche Ag Plasmodium sporozoite antigen
US5736358A (en) * 1991-05-17 1998-04-07 Rmf Dictagene S.A. Dictyostelid expression vector and method for expressing a desired protein
NL9100869A (nl) * 1991-05-17 1992-12-16 Univ Lausanne Dictyostelide expressievector en werkwijze voor het tot expressie brengen van een gewenst eiwit.
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
WO2005063805A1 (en) * 2003-12-23 2005-07-14 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8410063B (en) * 1984-01-30 1985-10-30 Smith Kline Rit Expression of human alpha-1-antitrypsin in yeast
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
NZ215023A (en) * 1985-02-07 1989-07-27 Smithkline Beckman Corp Vaccine against plasmodium falciparum and antigenic peptides

Also Published As

Publication number Publication date
HUT51332A (en) 1990-04-28
KR890700661A (ko) 1989-04-26
DK36988A (da) 1988-07-31
WO1988005817A1 (en) 1988-08-11
FI884485A (fi) 1988-09-29
AU1092588A (en) 1988-08-04
EP0278941A1 (en) 1988-08-17
FI884485A0 (fi) 1988-09-29
DK36988D0 (da) 1988-01-26

Similar Documents

Publication Publication Date Title
DK203187A (da) Human g-csf proteinekspression
DE68916693D1 (de) Molekular-Diagnose von Alzheimer-Krankheit.
DE69014358D1 (de) Kosmetisches Präparat.
PT80292B (pt) Preparacao de factor viii humano funcional
BR8804142A (pt) Protese de ligamento cruzado anterior
FI851336L (fi) Ny fysiologiskt aktiv human polypeptid.
FR2653334B1 (fr) Preparation cosmetique de bronzage.
BR9006934A (pt) Formulacoes aquosas estabilizadas de pequenos peptidios
MX9203069A (es) Vesticulacion espontanea de liposomas multilamelares.
PT86639A (pt) Expressao da proteina da fase de esporozoito de p. falciparum por leveduras
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE68905091D1 (de) Kosmetisches praeparat.
ES1006336Y (es) Cepillo de dientes infantil plegable.
DK250088A (da) Ophthalmologisk praeparat
IT8921128A0 (it) Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano.
TR23373A (tr) N'-suebstitueye-n,n'-diasilhidrazinlerin 5 ueyeli heterosiklik tuerevleri
MX9203727A (es) Produccion de interferon-beta2 humano recombinante
IT1218565B (it) Tonometro oculare
GB2199140B (en) Determination of anti-p falciparum sporozoite antibodies in human blood.
MX9207407A (es) Mejora de la biodisponibilidad de agentes terapeuticos proteoliticamente labiles.
ES2012433A4 (es) Descafeinizacion de estractos acuosos.
IT8820561A0 (it) Metodo immunoenzimatico in fase omogenea per la determinazione di anticorpi antisporozoita di plasmodium falciparum nel sangue umano.
NO884304D0 (no) Ekspresjon av p. falciparum circumsporosoittprotein hos gjaer.
BR8807102A (pt) Preparacao de novos adocantes de proteina
FR2602233B1 (fr) Derives de l'isoquinoleine

Legal Events

Date Code Title Description
FC3A Refusal

Effective date: 19940826